McDermott Will & Emery LLP has made its mark in SPAC IPOs and de-SPAC deals over recent years and has demonstrated further expertise in mainstream IPOs, follow-on offerings, private placements and at-the-market programs. Much of its equity offerings work has centred on the healthcare, fintech and technology industries of late; the firm is a market leader in the healthcare sector. Washington DC partner Thomas Conaghan co-heads the capital markets and public companies group alongside Eric Orsic in Chicago. The team was further reinforced by the recruitment of Howard Kleinman from Dechert LLP in 2023, while former head of the SPAC group Ari Edelman left the firm in March 2024. Named individuals are based in New York unless stated otherwise.
Legal 500 redaktioneller Kommentar
Auszeichnungen
Mandantenzufriedenheit
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
‘Caroline Samuelson provides extraordinary quality, timeliness and cost effectiveness in a very broad array of public and private company equity topics. I have been and am a heavy user of top law firms services - none better than this team.’
- 'The team is quick and responsive on novel issues.'
- 'Tom Conaghan has particularly deep knowledge of securities matters.'
Anwält*innen
Praxisleitung
Thomas Conaghan; Eric Orsic
Weitere Kernanwält*innen
Howard Kleinman; Robert Cohen; Caroline Samuelson